PubMed COVID-19 Clinical Care

No abstract

Identification of the risk factors and the high-risk groups which are most vulnerable is critical in COVID-19 disease management at a population level. Evaluating the efficacy of vaccination against infections is necessary to determine booster

CONCLUSION: In the context of the current Omicron epidemic and high vaccination rate in the population, it is feasible to receive PB-HSC from infected donors even for immunocompromised patients. This also provides some references for our later donor

CONCLUSION: A high SARS-CoV-2 IgG prevalence in unvaccinated children was indicative of previous exposure to potentially infected contacts. This implies in-person academic activities for children can be continued during future community transmission

Recently, COVID-19 becomes a hot topic and explicitly made people follow social distancing and quarantine practices all over the world. Meanwhile, it is arduous to visit medical professionals intermittently by the patients for fear of spreading the

Background: Low-income working-age US adults disproportionately experienced healthcare disruptions at the onset of the COVID-19 pandemic. Little is known about how healthcare access and cardiovascular risk factor management changed as the pandemic

Intelligent health monitoring systems are becoming more important and popular as technology advances. Nowadays, online services are replacing physical infrastructure in several domains including medical services as well. The COVID-19 pandemic has

CONCLUSIONS: Country estimates of vaccine hesitancy from the high-frequency phone surveys are correlated with but lower than those from earlier studies, which often relied on less representative survey samples. The results suggest that vaccine

CONCLUSION: Home prehabilitation achieved lower overall postoperative complications than standard care and reached significant improvements in 6MWT and CET. A strong correlation was observed between CET and 6MWT, which allows validation of 6MWT as a

Long COVID symptoms typically occur within 3 months of an initial COVID-19 infection, last for more than 2 months, and cannot be explained by other diagnoses. The most common symptoms include fatigue, dyspnea, coughing, and cognitive impairment. The